- Multiple factors contribute to changes in healthcare financing.
- Market Street’s different platforms provide capital markets and advisory guidance.
- With more than $3 billion in completed transactions, Market Street provides advisory and capital markets services for healthcare financings.
Healthcare and diagnostics operators are facing consolidation pressure, reimbursement uncertainty and more selective sponsors all at once. In that environment, how a capital raise is structured can matter as much as the business behind it. Market Street Capital is a boutique capital markets and financial advisory firm that works with established middle-market businesses navigating pivotal moments in their development, focusing on companies with enterprise values from $10 million to $1 billion.
Reimbursement is the first reason healthcare financing looks different right now. Clinical laboratories offer a clear example. The Consolidated Appropriations Act of 2026, signed Feb. 3, delayed Medicare lab fee schedule cuts through 2026. According to the Centers for Medicare & Medicaid Services (“CMS”), payments for affected tests may decline beginning in 2027, subject to a statutory phase-in cap of 15% per test per year through 2029; CMS published preliminary 2027 rates in September 2026, with final rates pending. The American Clinical Laboratory Association has said roughly 800 tests are exposed.
Uncertainty like this complicates underwriting. Healthcare-focused lenders dig deeper into revenue sources, separating Medicare, Medicaid, commercial insurance and private pay. They also weigh reimbursement rate changes and management agreement structures when assessing collateral and downside scenarios.
Fragmented subsectors are consolidating as operators seek scale. In diagnostics, national chains bring outcomes data at scale to payer negotiations. Regulatory and administrative burdens also weigh more heavily on small labs, which may favor larger operators. The pattern extends beyond labs. Physician medical groups accounted for 46% of first-quarter health services deal volume, up from 37% a year earlier, and private equity drove most deal flow through platform add-ons.
Sponsors remain active but are more discerning. Healthcare private equity posted record disclosed deal value above $191 billion in 2025. PwC nonetheless characterizes the first half of 2026 as a selective, conviction-led market, with buyers favoring reimbursement visibility, margin durability and execution readiness. Deal volume softened even as value held up. Contracted payer relationships and recurring revenue command the strongest pricing, while material investigations or audit findings may affect valuation or transaction execution.
Those conditions may affect healthcare financing. Lenders may consider reimbursement diversification and documented compliance controls. Healthcare accounted for roughly 22% of U.S. direct lending issuance through March 2026, the largest share of any sector, but RSM cautions that the easy phase of private credit in healthcare has passed. Lenders expect new deals to carry lower leverage and stronger protections. Depending on cash flow, collateral and investor requirements, a financing may combine senior debt with mezzanine financing or minority equity.
Healthcare diligence can involve sector-specific review. Alongside standard financial review, buyers and lenders scrutinize payer contracts, analyze payer mix and denial rates, and map financial relationships against the Stark Law and Anti-Kickback Statute. That review matters because potential compliance risks may carry over with the business in an acquisition.
This is where Market Street Capital fits. Its Debt Capital Markets & Specialty Lending practice works with middle-market clients seeking financing from banks, private credit funds, insurance companies and specialty finance providers. It advises on senior debt, unitranche and mezzanine financing, and asset-based lending tied to receivables. Its Private Equity Raises practice advises on growth funding and recapitalizations involving private equity, family offices and institutional capital. Securities placement services, where applicable, are provided through Pickwick Capital Partners, LLC, Member FINRA/SIPC. No capital raise or transaction outcome is assured.
The firm’s broader investment banking platform addresses consolidation directly. Its Mergers & Acquisitions team handles sell-side and buy-side advisory, including work for private equity sponsors building platforms. Market Street’s valuation capabilities support transaction planning and capital events.
The firm also maintains a syndication network of more than 8,000 investors, family offices, venture capital firms and banks and highlights its access to private equity sponsors and strategic acquirers. Such relationships may assist in identifying counterparties with relevant mandates. With more than $3 billion in completed transactions, Market Street offers capital markets and advisory services relevant to healthcare financings.
Healthcare capital raises demand more layered diligence and more selective sponsor targeting than most middle-market sectors. Reimbursement exposure, compliance history and payer concentration all shape what lenders will extend and what sponsors will pay. Market Street Capital offers advisory services addressing capital markets and sector-specific financing considerations.
For more information about the company, visit www.MarketStreetCP.com.
NOTE TO INVESTORS: The latest news and updates relating to Market Street are available in the company’s newsroom at https://ibn.fm/MarketSt
Disclosures:
This article is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any such offer may be made only pursuant to definitive offering materials and applicable transaction documents.
Nothing in this article is tax, legal or accounting advice. Readers should consult their own advisers.
Market data and third-party information are from sources believed to be reliable but have not been independently verified. No representation is made as to accuracy or completeness. Statements about financing structures and transaction outcomes are general in nature; no financing or transaction outcome can be assured. Any investment in securities is illiquid and speculative and is subject to a risk of loss, including a risk of the total loss of principal. Market Street Capital and its associated persons may have conflicts of interest, including transaction-based compensation, in connection with the services described.
Broker-dealer services are provided by Pickwick Capital Partners, LLC, Member FINRA/SIPC.
